Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00392548
Status:
UNKNOWN
Last Update Posted:
2006-10-26
First Post:
2006-10-25
Brief Title:
URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol
Sponsor:
Tel-Aviv Sourasky Medical Center
Organization:
Tel-Aviv Sourasky Medical Center
Study Overview
Official Title:
Urinary VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme Prospective Determination of a Predictive Value for Recurrence
Status:
UNKNOWN
Status Verified Date:
2006-09
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study of the urinary vascular endothelial growth factor VEGF levels in patients with glioblastoma receiving standard therapy
Hypothesis that urinary VEGF levels can serve as a predictor of treatment response and survival
Hypothesis that urinary VEGF levels can serve as a predictor of treatment response and survival
Detailed Description:
Measurement of urinary VEGF levels pre treatmentimmediately after treatment and 1 month after treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None